Does TREPROSTINIL Cause Application site erosion? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Application site erosion have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
5
Reports of Application site erosion with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Application site erosion From TREPROSTINIL?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Application site erosion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Application site erosion?
BUPRENORPHINE (135)
INGENOL MEBUTATE (123)
SUMATRIPTAN (71)
FENTANYL (65)
ESTRADIOL (39)
MECHLORETHAMINE (36)
NICOTINE (35)
MINOXIDIL (23)
ESTRADIOL\NORETHINDRONE (18)
METHYLPHENIDATE (18)
Which TREPROSTINIL Alternatives Have Lower Application site erosion Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE